CYP24 Antibodies

Santa Cruz Biotechnology provides a broad selection of CYP24 monoclonal antibodies for research focused on understanding cytochrome P450 24A1. CYP24 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CYP24, also known as cytochrome P450 24A1, is a key enzyme involved in the metabolism of vitamin D, playing a crucial role in calcium homeostasis and bone health. Dysregulation of CYP24 has been implicated in various diseases, including cancer and metabolic disorders, making it a significant target for therapeutic intervention. Understanding the function and regulation of CYP24 is essential for advancing research in endocrinology and oncology. CYP24 monoclonal antibodies enable precise detection and quantification of CYP24 expression levels in various biological samples. Researchers can utilize CYP24 monoclonal antibodies to investigate cellular localization patterns and protein-protein interactions. Advanced research techniques incorporating CYP24 monoclonal antibodies help unlock new insights into vitamin D metabolism pathways. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of CYP24 and its role in human health and disease.